Intellia Therapeutics Appoints Derek Hicks as Chief Business Officer

Go back to Intellia Therapeutics Appoints Derek Hicks as Chief Business Officer
(NASDAQ: NTLA) Delayed: 13.02 -1.2 (8.44%)
Previous Close $14.22    52 Week High $30.40 
Open $13.76    52 Week Low $11.86 
Day High $13.77    P/E N/A 
Day Low $12.77    EPS $0.00 
Volume 7,477,004